Semnur Pharmaceuticals, Inc. (OTC:SMNR) IPO
IPO
Went public as Denali Capital Acquisition Corp., a blank check company (SPAC). Priced at US$10.00 a unit on Apr 6, 2022.
- Price
- US$10.00 a unit
- Units offered
- 7,500,000 units
- Offering size
- US$75 million
- Underwriters' option
- Up to 1,125,000 more units
- Listing
- DECAU on the Nasdaq Global Market
- Underwriters
- Tiger Brokers, EF Hutton · In the order on the cover
- Units delivered
- On or about Apr 11, 2022
Steps
| Step | When |
|---|---|
| Filed publicly | Mar 1, 2022 |
| Amended 3 times | Newest Apr 5, 2022 |
| Shares registered with an exchange | Apr 6, 2022 |
| Declared effective by the SEC | Apr 6, 2022 |
| Final prospectus, with the price | Apr 7, 2022 |
Filings
| Filing | Filed |
|---|---|
| 424B3 · Prospectus | Apr 7, 2022 |
| EFFECT · Notice that a registration is effective | Apr 6, 2022 |
| CERT · Exchange's certificate of listing | Apr 6, 2022 |
| 8-A12B · Registration of shares for listing on an exchange | Apr 6, 2022 |
| S-1/A · Registration statement, amended | Apr 5, 2022 |
| CORRESP · Letter to the SEC | Apr 4, 2022 |
| CORRESP · Letter to the SEC | Apr 4, 2022 |
| S-1/A · Registration statement, amended | Mar 28, 2022 |
| S-1/A · Registration statement, amended | Mar 22, 2022 |
| UPLOAD · Letter from the SEC | Mar 10, 2022 |
| S-1 · Registration statement | Mar 1, 2022 |
From the cover of the final prospectus (424B3) filed Apr 7, 2022